Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/38486| Title: | Idelalisib induced CMV gastrointestinal disease: the need for vigilance with novel therapies. | Authors: | Kumar B. ;Gan T.E.;Low M.S.Y.;Goldring L. | Institution: | (Goldring, Low) Department of Immunology, Monash University, Prahran, Vic, Australia (Kumar) Department of Anatomical Pathology, Monash Health, Clayton, Vic, Australia (Gan, Low) Monash Haematology, Monash Health, Clayton, Vic, Australia (Low) Immunology Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Vic, Australia (Low) Department of Medical Biology, The University of Melbourne, Parkville, Vic, Australia | Issue Date: | 27-Jul-2017 | Copyright year: | 2017 | Publisher: | Elsevier B.V. (E-mail: kathiest.clai@apta.org) | Place of publication: | United States | Publication information: | Pathology. 49 (5) (pp 555-557), 2017. Date of Publication: August 2017. | Journal: | Pathology | DOI: | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1016/j.pathol.2017.03.009 | PubMed URL: | 28693750 [http://www.ncbi.nlm.nih.gov/pubmed/?term=28693750] | ISSN: | 0031-3025 | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/38486 | Type: | Letter | Type of Clinical Study or Trial: | Case series or case report |
| Appears in Collections: | Articles |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.